Zura Bio Limited Class A Ordinary Shares
Here’s whether Zura Bio Limited Class A Ordinary Shares (ZURA) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Positives: strong 1-year return of +195.7%. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-7.08% over 10 days); RSI 25 — oversold; 3-month momentum negative (-51.7%); rising volume on a downtrend (distribution, 1.33x avg). Currently 54.3% off its 52-week high. Score: -5/7.
ZURA is trading below its 200-day MA ($4.57) — a key warning sign the longer-term trend is under pressure. An RSI of 24.8 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of +195.7% compares to +24.4% for SPY (beat the market by 171.3%). The current 54.3% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.